Morgan Stanley Alector, Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Alector, Inc. stock. As of the latest transaction made, Morgan Stanley holds 346,707 shares of ALEC stock, worth $579,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

346,707

Previous 650,541 46.7%

Holding current value

$579,000

Previous $1.23 Million 65.34%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.23 - $2.06 $373,715 - $625,898	-303,834 Reduced 46.7%	346,707 $426,000
Q4 2024 Feb 14, 2025	SELL	$1.72 - $6.06 $6.37 Million - $22.5 Million	-3,705,229 Reduced 85.06%	650,541 $1.23 Million
Q3 2024 May 14, 2025	BUY	$4.34 - $6.58 $5.86 Million - $8.89 Million	1,350,697 Added 44.95%	4,355,770 $20.3 Million
Q3 2024 Nov 14, 2024	BUY	$4.34 - $6.58 $5.86 Million - $8.89 Million	1,350,697 Added 44.95%	4,355,770 $20.3 Million
Q2 2024 May 14, 2025	BUY	$4.19 - $6.23 $9.87 Million - $14.7 Million	2,354,532 Added 361.93%	3,005,073 $13.6 Million
Q2 2024 Oct 17, 2024	SELL	$4.19 - $6.23 $1.26 Million - $1.87 Million	-299,903 Reduced 9.07%	3,005,073 $13.6 Million
Q2 2024 Aug 14, 2024	SELL	$4.19 - $6.23 $1.26 Million - $1.87 Million	-299,903 Reduced 9.07%	3,005,073 $13.6 Million
Q1 2024 Oct 17, 2024	BUY	$5.69 - $8.08 $1.71 Million - $2.42 Million	299,903 Added 9.98%	3,304,976 $19.9 Million
Q1 2024 Aug 16, 2024	SELL	$5.69 - $8.08 $7.65 Million - $10.9 Million	-1,345,215 Reduced 28.93%	3,304,976 $19.9 Million
Q1 2024 May 15, 2024	SELL	$5.69 - $8.08 $7.65 Million - $10.9 Million	-1,345,215 Reduced 28.93%	3,304,976 $19.9 Million
Q4 2023 Aug 16, 2024	BUY	$3.77 - $8.39 $6.2 Million - $13.8 Million	1,645,118 Added 54.74%	4,650,191 $37.1 Million
Q4 2023 Feb 13, 2024	BUY	$3.77 - $8.39 $4.95 Million - $11 Million	1,312,805 Added 39.34%	4,650,191 $37.1 Million
Q3 2023 Nov 15, 2023	BUY	$5.2 - $8.77 $8.35 Million - $14.1 Million	1,605,293 Added 92.68%	3,337,386 $21.6 Million
Q2 2023 Aug 14, 2023	BUY	$5.86 - $7.93 $7.52 Million - $10.2 Million	1,283,131 Added 285.8%	1,732,093 $10.4 Million
Q1 2023 May 15, 2023	SELL	$5.85 - $9.84 $854,088 - $1.44 Million	-145,998 Reduced 24.54%	448,962 $2.78 Million
Q4 2022 Feb 14, 2023	BUY	$6.88 - $9.55 $160,145 - $222,295	23,277 Added 4.07%	594,960 $5.49 Million
Q3 2022 Nov 14, 2022	SELL	$8.19 - $13.2 $1.98 Million - $3.2 Million	-242,189 Reduced 29.76%	571,683 $5.41 Million
Q2 2022 Oct 27, 2022	BUY	$7.65 - $14.24 $1.51 Million - $2.81 Million	197,256 Added 31.99%	813,872 $8.27 Million
Q2 2022 Aug 15, 2022	BUY	$7.65 - $14.24 $1.51 Million - $2.81 Million	197,256 Added 31.99%	813,872 $8.27 Million
Q1 2022 Oct 27, 2022	SELL	$13.02 - $20.78 $2.57 Million - $4.1 Million	-197,256 Reduced 24.24%	616,616 $8.79 Million
Q1 2022 May 13, 2022	SELL	$13.02 - $20.78 $17.2 Million - $27.5 Million	-1,321,644 Reduced 68.19%	616,616 $8.79 Million
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $21.9 Million - $28.9 Million	1,133,000 Added 140.7%	1,938,260 $40 Million
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $17.4 Million - $31.8 Million	805,260 New	805,260 $18.4 Million

Others Institutions Holding ALEC

# of Institutions

146

Shares Held

55.4M

Call Options Held

56.4K

Put Options Held

23.2K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $138M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account